December 01, 2023
National Cancer Institute (NCI)
The purpose of this Notice is to correct the Matrix of Key Dates (i.e., Application Due Dates, Review and Award Cycles) for PAR-23-308, Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional).
The following section of PAR-23-308 has been corrected:
Currently, it reads:
Application Due Dates | Review and Award Cycles | ||||
---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
January 16, 2024 | January 16, 2024 | Not Applicable | June 2024 | August 2024 | October 2024 |
Expiration Date: January 17, 2024
Corrected to read (in bold italics):
Application Due Dates | Review and Award Cycles | ||||
---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
January 16, 2024 | January 16, 2024 | Not Applicable | June 2024 | August 2024 | October 2024 |
October 9, 2024 | October 9, 2024 | Not Applicable | January 2025 | May 2025 | July 2025 |
October 9, 2025 | October 9, 2025 | Not Applicable | January 2026 | May 2026 | July 2026 |
Expiration Date: October 10, 2025
All other aspects of PAR-23-308 remain unchanged.
Scientific/Research Contact(s)
Sandra L. San Miguel-Majors, DrPH, M.S.
National Cancer Institute (NCI)
Telephone: 240-276-5977
Email: [email protected]
Behrous Davani, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6170
Email: [email protected]
LeeAnn Bailey, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6170
Email: [email protected]
Peer Review Contact(s)
Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]
Financial/Grants Management Contact(s)
Dawn Mitchum
National Cancer Institute (NCI)
Telephone: 202-276-5699
Email: [email protected]